THE DEAL, AT A GLANCE
From the announcementDNA X
01Who is involvedBacked by Thrive Capital, includes participation from existing backers Alphabet, GV, new investors MGXFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedDNA X raised $8.1M Series B, announced 2026-07-02From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersDNA X’s $8.1M Series B is a below-median Digital Health financing in a sector that still shows active capital flow, with 26 other trailing 30-day rounds totaling $1538M.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
DNA X · Financing Record
Explore source-linked visual explanations for DNA X. Unsupported claims are withheld while source review continues.
Record 7165 · Recorded date: 2026-07-02
Explore company records →